This study analysed the potential effects of removing parallel imports on prices and government and patients’ health expenditure. The researcher from the University of Melbourne developed a model based on the Danish Market for Statins and found out that a ban on parallel imports would increase the prices of patented medicines and also generics, although this increase would be even larger if the medicine is still under patent protection. The healthcare expenditure of the government would increase while the consumers’ welfare would decrease.